Gables Capital Management Inc. Obs Eva Sa Transaction History

Gables Capital Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 30, 2019	SELL	$8.22 - $11.2 $8,220 - $11,200	-1,000 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$10.05 - $14.25 $10,050 - $14,250	-1,000 Reduced 50.0%	1,000 $11,000
Q4 2018 Feb 08, 2019	BUY	$10.8 - $17.94 $21,600 - $35,880	2,000 New	2,000 $25,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Gables Capital Management Inc. with notifications on news.